Research Funding Opportunities

Student Affairs Personnel
Educational Resources
Historical Documents
Student Center
Residents and Fellows
Institutional Research
Federal Grants Search
Pharmacy Faculty Research Grant Data
Pharmacy Workforce Center
Practice Based Research Networks
FDA Collaboration
Research Funding Opportunities
Consultants and Speakers Bureau

Research Funding Opportunities 

Please regularly visit the following Web sites and directly search for funding opportunities and deadlines in your research field.

Federal Agencies A central storehouse that lists all current funding opportunities from agencies of the United States government, including NIH, NSF, DOD, EPA, DOE, CDC, FDA, AHRQ, CMMS, and so on.

NIH Grants & Funding: A searchable database maintained by the NIH Office of Extramural Research on currently available biomedical research funding and training opportunities related to human health and diseases.

NSF Funding: The Foundation supports basic research and education in most fields, including biological, chemical, environmental, social, behavioral and economical sciences, collaborative research between universities and industry, and graduate and postdoctoral fellowships.

USDA NIFA Grants: Supports research and fellowships on nutrition and health, education, environment, biotechnology and genomics, economics and community development.

AHRQ Funding & Grants: Supports research to improve the quality, safety, efficiency, and effectiveness of healthcare for all Americans.

PCORI Funding: Funds research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed healthcare decisions.

DOD Grants: Department of Defense Appropriations Act provides funding for many peer reviewed biomedical research programs managed by the Department of Defense (DOD) Office of Congressionally Directed Medical Research Programs (CDMRP). Such programs are usually announced between May and July for the following fiscal year.

DARPA (Defense Advanced Research Projects Agency): Funds research that investigates approaches advancing science, techonology, biology, engineering and computer sciences.


Non-Federal Research Associations and Foundations (many of them offer New Investigator Awards)

Proposal Central (Alzheimer’s Association, American Association for Cancer Research, Neilsen Foundation, Cystic Fibrosis Foundation, Epilepsy Foundation, Juvenile Diabetes Research Foundation, Lupus Foundation of America, Melanoma Research Foundation, Muscular Dystrophy Association, The Leukemia & Lymphoma Society, and others)

American Liver Foundation

American Asthma Foundation

American Brain Tumor Association 

American Diabetes Association

American Heart Association

American Institute for Cancer Research

American Lung Association

American Respiratory Care Foundation

Arthritis Foundation

Arthritis National Research Foundation

Beckman Foundation

Cancer Research Institute

Gates Foundation

Human Frontier Science Program

NACDS Foundation

National Foundation for Infectious Diseases

National Pharmaceutical Council

Prostate Cancer Foundation

Susan G. Komen for the Cure

Wellcome Trust

International Rett Syndrome Foundation

Additional Research Funding Resources and Opportunities

Standard due dates for competing NIH applications

PhRMA Foundation Pre Doctoral Fellowships for Health Outcomes aim at supporting promising students during their thesis research. The program provides a stipend and funds to cover costs incidental to the training. The program assumes that the fellows will devote full-time (including summers) to their research. The PhRMA Foundation fellowship may not be used as a supplement to funds from other fellowships, traineeships or assistantships. The focus of the program is to assist in the pre doctoral training of the candidate. It should not be viewed as a program to fund a research project. Deadline: February 1, 2016

PhRMA Foundation Post Doctoral Fellowships for Health Outcomes is to support postdoctoral career development activities of individuals prepared (or preparing) to engage in research that will strengthen representation of health outcomes in schools of pharmacy, medicine, nursing and public health. Deadline: February 1, 2016

PhRMA Foundation Post Doctoral Fellowships for Translational Medicine and Therapeutics is to support multidisciplinary/collaborative research that further develops the recipient in the field of translational medicine and therapeutics. These awards help bring results of basic research to patients and physicians. Deadline: February 1, 2016

PhRMA Foundation Research Starter Grants for Health Outcomes offer financial support to individuals beginning their independent research careers at the faculty level. This program supports individuals beginning independent research careers in academia who do not have other substantial sources of research funding. Health outcomes research spans a broad spectrum of issues from studies evaluating the effectiveness of a particular pharmaceutical intervention to the impact of reimbursement policies on the outcomes of care. It also ranges from the development and use of tools to perform patient-based assessments to analyses of the best way to disseminate the results of outcomes research to providers or consumers to encourage behavior change. Deadline: February 1, 2016

PhRMA Foundation Research Starter Grants for Translational Medicine and Therapeutics are starter grants to support individuals at the beginning of their independent research careers in the field of translational medicine and therapeutics.  Applicants must hold the academic rank of Assistant Professor or Research Assistant Professor within a tenure track or research track, respectively.  Instructors, if eligible to apply for research funding by their institution, are also eligible for this award. Deadline: February 1, 2016

PhRMA Foundation Sabbatical Fellowships for Health Outcomes provide stipend support for individuals engaged in a multidisciplinary research training program that will create or extend their credentials in health outcomes. The purpose (intent) of this program is to enable faculty with active research programs to work outside of their home institution to learn new skills or develop new collaborations that will enhance their research and research training capabilities in health outcomes. Deadline: February 1, 2016

NIH Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01) is to promote translation of basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase drug discovery and development efforts in areas relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, hematology, and specific aspects of cystic fibrosis. Applications are accepted according to the standard NIH deadline schedule until expiration of the notice. Expiration Date: March 8, 2016

NIH Discovery of In Vivo Chemical Probes (R01) support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes. It is expected that applicants will have in hand the starting compounds ("validated hits") for chemical optimization and bioassays for testing new analog compounds. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease targets and processes. Applications are accepted according to the standard AIDS dates until expiration of the notice. Expiration Date: September 8, 2017

NIH Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN receive funding for activities to be conducted in their own laboratories and the opportunity to collaborate with NIH-funded consultants and contract research organizations (CROs) that specialize in medicinal chemistry, pharmacokinetics, toxicology, formulations development, chemical synthesis under Good Manufacturing Practices (GMP), and Phase I clinical testing. Projects can enter either at the Discovery stage, to optimize well-validated hit compounds through medicinal chemistry, or at the Development stage, to advance development candidates through Investigational New Drug (IND)-enabling toxicology studies and phase I clinical testing. Multiple deadline dates listed through February 2017

NIH Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) supports research that advances compounds towards FDA approval by leveraging NIDA funds with the strengths and resources of outside organizations, such as for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, and small businesses. Multiple deadline dates listed through September 2016

NIH NeuroNEXT Clinical Trials (U01) encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required fordesigning a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests. Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol. Deadlines: December 3, 2015 or April 4, 2016

Worldwide Cancer Research Grants fund scientific research that may, in future, help reduce the incidence of cancer or improve cancer survival. The sponsor awards project grants to support basic or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer. The PI must be employed at a recognized, non-profit academic research institution anywhere in the world. Deadline: April 29, 2016 deadline

Last updated on: 11/11/2015 9:52 AM 

 Contact Information

Kirsten F. Block, Ph.D.
Associate Director of Research and Graduate Programs
703-739-2330 ext. 1042

© 2016 American Association of Colleges of Pharmacy
1727 King Street | Alexandria, VA  22314 | (703) 739-2330 | Fax: (703) 836-8982 |